NCT04608968 Pediatric Perioperative Satisfaction Questionnaire
| NCT ID | NCT04608968 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Montpellier |
| Condition | Perioperative |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2020-09-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2020-09-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to develop and validate a self-report questionnaire to evalutate the satisfaction of the children after surgery.
Eligibility Criteria
Inclusion criteria: * children 7 years and older * elective surgery * general anesthesia * abiliy to understand and read questions Exclusion criteria: * emergency * cognitive trouble * intellectual disability
Contact & Investigator
Christophe DADURE, PhD
STUDY DIRECTOR
University Hospital, Montpellier
Frequently Asked Questions
Who can join the NCT04608968 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 17 Years, studying Perioperative. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04608968 currently recruiting?
Yes, NCT04608968 is actively recruiting participants. Contact the research team at s-bringuierbranchereau@chu-montpellier.fr for enrollment information.
Where is the NCT04608968 trial being conducted?
This trial is being conducted at Montpellier, France, Bordeaux, France, Grenoble, France, Nîmes, France and 2 additional locations.
Who is sponsoring the NCT04608968 clinical trial?
NCT04608968 is sponsored by University Hospital, Montpellier. The principal investigator is Christophe DADURE, PhD at University Hospital, Montpellier. The trial plans to enroll 600 participants.